WebApr 22, 2024 · Hikma Pharmaceuticals has acquired US-based generic sterile injectables company Custopharm from Water Street Healthcare Partners in a deal valued at $425m. … WebCustopharm is a customer-focused service company that provides personalized cost-effective chemistry and manufacturing controls Acquired by Hikma Pharmaceuticals Carlsbad, California, United States 11-50 Private Equity Private www.custopharm.com/ 398,691 Highlights Contacts 19 Employee Profiles 3 Investors 1 Similar Companies 3
Hikma strengthens US Injectables business through …
WebRespondent Hikma Pharmaceuticals PLC (“Hikma”), a corporation subject to the jurisdiction of the Commission, agreed to acquire Respondent Custopharm, Inc. (“Custopharm”), a subsidiary ... Biosciences and Teva Pharmaceutical Industries. Custopharm received FDA approval to market its injectable TCA product on January 19, 2024. Hikma has ... WebJun 7, 2024 · 06.07.22 PHILADELPHIA – Troutman Pepper client Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, has acquired Custopharm Inc. from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Read a company press release about the acquisition. flight tsa
Hikma Pharmaceuticals
WebThe result: Custopharm attained a prolific output of 13 product approvals, including four first-to-market ANDA approvals and a competitive generic therapy designation, in six … WebApr 18, 2024 · Case Summary. As a condition of Hikma Pharmaceuticals PLC’s $375 million acquisition of generic drug services company Custopharm, Inc., the Federal Trade … WebApr 19, 2024 · Hikma is a multinational pharmaceutical company with U.S. headquarters in Berkeley Heights, NJ. It manufactures branded and generic products, including generic … greatek ac1200